ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 16

$1.22M Total Retail Price of All Prescriptions

Rank: 2 out of 16

428 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

10% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 21,727 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 35.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,310 1,166 1 1
FUROSEMIDE 978 933 2 3
SIMVASTATIN 844 761 3 2
DONEPEZIL HCL 625 625 4 9
METOPROLOL TARTRATE 597 556 5 8
LEVOTHYROXINE SODIUM 583 564 6 6
OMEPRAZOLE 563 540 7 5
LISINOPRIL 524 473 8 4
AMLODIPINE BESYLATE 471 450 9 7
NAMENDA 441 434 10 18
TRAZODONE HCL 421 400 11 11
CITALOPRAM HBR 407 384 12 12
MIRTAZAPINE 388 375 13 16
SERTRALINE HCL 384 367 14 10
ATORVASTATIN CALCIUM 356 340 15 13
HYDROCHLOROTHIAZIDE 330 297 16 14
QUETIAPINE FUMARATE 326 324 17 22
ALENDRONATE SODIUM 318 306 18 25
METFORMIN HCL 299 266 19 20
ATENOLOL 298 286 20 17
POLYETHYLENE GLYCOL 3350 296 276 21 24
GABAPENTIN 284 235 22 19
POTASSIUM CHLORIDE 278 278 23 43
BISOPROLOL FUMARATE 262 262 24 65
RAMIPRIL 260 249 25 52
LANTUS 223 184 26 26
ALLOPURINOL 219 201 27 29
ESCITALOPRAM OXALATE 210 207 28 38
HYDROCODONE-ACETAMINOPHEN 198 161 S3 29 15
TAMSULOSIN HCL 198 198 29 21
EXELON 194 181 31 56
IPRATROPIUM-ALBUTEROL 193 187 32 45
LOVASTATIN 186 186 33 44
SPIRIVA 180 176 34 31
CYMBALTA 175 155 35 33
CLOPIDOGREL 167 153 36 34
TRAMADOL HCL 159 158 37 34
FENOFIBRATE 158 141 38 62
DIOVAN 154 154 39 30
KLOR-CON M20 143 140 40 46
DIGOXIN 143 133 40 47
SEROQUEL 134 131 42 63
DILTIAZEM 24HR CD 129 116 43 61
DILTIAZEM 24HR ER 128 122 44 80
RANITIDINE HCL 128 128 44 51
LIDODERM 128 127 44 55
PANTOPRAZOLE SODIUM 122 109 47 32
PRAVASTATIN SODIUM 120 120 48 28
ADVAIR DISKUS 117 107 49 39
ZOLPIDEM TARTRATE 116 91 50 41
LACTULOSE 115 115 51 74
LATANOPROST 114 114 52 66
RISPERIDONE 113 111 53 36
GLIPIZIDE 112 96 54 42
LOSARTAN POTASSIUM 102 102 55 27
GLIPIZIDE ER 102 74 55 94
FINASTERIDE 100 100 57 54
VENLAFAXINE HCL ER 97 77 58 49
ENABLEX 92 92 59 136
OXYBUTYNIN CHLORIDE ER 88 81 60 95
DIVALPROEX SODIUM 88 87 60 69
PROAIR HFA 84 79 62 73
PREDNISONE 83 79 63 40
FLUTICASONE PROPIONATE 83 71 63 58
FLOVENT HFA 83 83 63 102
ENALAPRIL MALEATE 77 77 66 59
PLAVIX 75 69 67 60
NYSTOP 74 70 68 149
MECLIZINE HCL 73 56 69 77
CARBIDOPA-LEVODOPA 73 53 69 53
CIPROFLOXACIN HCL 72 69 71 57
SPIRONOLACTONE 70 67 72 99
ISOSORBIDE MONONITRATE ER 69 69 73 48
DOXAZOSIN MESYLATE 69 69 73 70
TAMIFLU 67 66 75 109
BACLOFEN 64 28 76 112
BYSTOLIC 64 64 76 112
PAROXETINE HCL 62 62 78 68
CARVEDILOL 59 59 79 71
HYDRALAZINE HCL 59 59 79 87
AVELOX 58 55 81 167
ISOSORBIDE DINITRATE 56 56 82 172
CEPHALEXIN 55 53 83 108
BUPROPION HCL SR 55 49 83 174
TIMOLOL MALEATE 54 54 85 124
NOVOLIN R 54 46 85 111
NAPROXEN 54 52 85 89
CARAFATE 54 54 85 178
VOLTAREN 53 43 89 182
CRESTOR 52 34 90 50
GLIMEPIRIDE 52 52 90 126
TRIAMTERENE-HCTZ 51 51 92 75
GLYBURIDE 50 50 R 93 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.